Inflammation and adaptive immunity in Parkinson's disease.
about
The biomarkers of immune dysregulation and inflammation response in Parkinson diseaseMyeloid Dendritic Cells are Potential Players in Human Neurodegenerative DiseasesCellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's diseaseVaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?Isothiocyanates Are Promising Compounds against Oxidative Stress, Neuroinflammation and Cell Death that May Benefit Neurodegeneration in Parkinson's DiseaseHow Can We Treat Cancer Disease Not Cancer Cells?Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's DiseaseAnti-human α-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-α-synuclein rat model of Parkinson's disease.Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disordersChaperoned amyloid proteins for immune manipulation: α-Synuclein/Hsp70 shifts immunity toward a modulatory phenotypeA novel role of microglial NADPH oxidase in mediating extra-synaptic function of norepinephrine in regulating brain immune homeostasis.Identification of Multiple QTLs Linked to Neuropathology in the Engrailed-1 Heterozygous Mouse Model of Parkinson's Disease.Phenome-based gene discovery provides information about Parkinson's disease drug targetsA Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative DisordersDifferential effect of DJ-1/PARK7 on development of natural and induced regulatory T cells.Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice.CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease.Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.Treating non-motor symptoms of Parkinson's disease with transplantation of stem cellsAssociation Analysis of Proteasome Subunits and Transporter Associated with Antigen Processing on Chinese Patients with Parkinson's DiseaseIdentification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons.Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model.Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease.Association of Parkinson disease with structural and regulatory variants in the HLA regionImmortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activityα-Synuclein in Parkinson's disease.Modulating microglia activity with PPAR-γ agonists: a promising therapy for Parkinson's disease?Innate inflammation in Parkinson's disease.The role of inflammation in sporadic and familial Parkinson's disease.Integrating pathways of Parkinson's disease in a molecular interaction map.Animal models of neurodegenerative diseases.Inflammation in neurodegenerative diseases--an update.Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair.Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases.Beyond muscles: The untapped potential of creatine.Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial.Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids.SIRT3 Acts as a Neuroprotective Agent in Rotenone-Induced Parkinson Cell Model.
P2860
Q26738459-7DB299C1-025B-465A-BF5F-B54766545E71Q26770676-07176836-5424-4F73-A55E-3121135BC20CQ26849232-15EA6D09-C2FC-49BD-B26C-020E42E43CB3Q27015811-F691712D-CAD3-4F8A-9418-8B870E2D633EQ28079206-09617323-4DF4-4017-8FD3-9E322921FC97Q28558823-16E83354-25E5-4147-AD51-8A80FFA127B1Q33920647-C8CAE0C5-0BBC-4C9A-812A-D341C88777DEQ35058359-FAF48A0E-6B2C-4010-B835-19AAC501E8C2Q35059951-1E2ED34D-E12E-40F3-B5AD-74D4196CE8E0Q35068792-5C3EF3A1-BB9F-4093-BD12-EAEB430D7A37Q35246024-17832BCA-4C70-4166-B0E3-5E5086020EAAQ35285839-B1495DBA-DA1D-4327-8288-058BB7BE9DBDQ35514746-E20B9354-E77A-4601-8CEE-561C98154FA5Q36109874-F03072BA-A9FE-4FB0-ACAC-07B1089A6BBEQ36120753-3C72EE3D-963C-4CBD-A56E-487ABA2EB42CQ36326816-1A58BBB5-52A1-4C67-A1D4-A9F37CFE5F33Q36346401-89E2A51A-8915-42D4-ACF3-4F79D25FAC55Q36373813-42553B3D-6FC6-4758-A748-F441A2372770Q36449229-7AB43975-5D67-414B-BAB4-7EC513E85E1AQ36474039-FA957428-DCE7-4427-816A-1936BA0CF626Q36790753-0871A9E4-EE08-4095-9F87-B5831E689158Q36856560-D3DC5A82-F5B3-4764-86C5-63528242BBE1Q37024615-52704041-6A35-4518-B55E-1D70B206FE26Q37057806-C6A095D7-8AFF-4E47-A31F-7D04CB57BADDQ37274056-C2C57925-236F-4812-9793-47553AEE1291Q37298135-FE923E32-B41F-4B69-A2D5-6CF82659F79BQ37425957-23AC1557-FA1E-4B85-87F6-CC193DB0E7A7Q37987146-0D4E992A-0498-4B93-B384-D1D394342886Q38032481-D23BF298-F2FC-4CA6-A777-ECB467904788Q38040993-1CB9ED17-13A3-487C-8E75-25777A71EA4CQ38105903-DFFDF9ED-8781-410A-839D-0ADEFF403A8EQ38119873-D1829E29-F63E-4550-B075-E0A4ACFC9BFDQ38165759-ADEBA024-5551-487E-9BC7-07E4EE02BCAAQ38170472-A68669A5-FDE8-402D-82F8-DD34560153C4Q38264485-313F3C18-5713-4CA1-BEF9-95EF9EBBA493Q38674162-299CB4C2-BAE2-4C7E-B809-7512E9C43779Q38700215-49499B5C-C9EB-47CA-9FFD-7A367AD9E35DQ38709455-A6AB0AAA-3A66-4926-B84E-687E78BDB487Q38774697-11A21E1A-D44D-45E8-8E2E-CF1057832FC0Q38780130-C76D293C-5B9A-4C8C-A69B-304225BB1E07
P2860
Inflammation and adaptive immunity in Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Inflammation and adaptive immunity in Parkinson's disease.
@en
Inflammation and adaptive immunity in Parkinson's disease.
@nl
type
label
Inflammation and adaptive immunity in Parkinson's disease.
@en
Inflammation and adaptive immunity in Parkinson's disease.
@nl
prefLabel
Inflammation and adaptive immunity in Parkinson's disease.
@en
Inflammation and adaptive immunity in Parkinson's disease.
@nl
P2093
P2860
P1476
Inflammation and adaptive immunity in Parkinson's disease.
@en
P2093
David K Stone
Howard E Gendelman
Jessica A Hutter-Saunders
R Lee Mosley
P2860
P304
P356
10.1101/CSHPERSPECT.A009381
P577
2012-01-01T00:00:00Z